VEGFA and hypertensive disorder: While VEGF inhibition represents a valuable anticancer strategy, its cardiovascular complications, including hypertension, ventricular remodeling, and mitochondrial damage, necessitate careful monitoring and consideration of cardioprotective interventions in clinical practice.